Jason Luke
MD
Associate Professor
👥Biography 个人简介
Jason Luke at UPMC has contributed to melanoma immunotherapy clinical research and to developing STING (stimulator of interferon genes) agonists as cancer immunotherapy agents. His work on combining innate immune activation strategies with checkpoint blockade to convert immunologically cold tumors to hot tumors, and his contributions to melanoma immunotherapy combination trials, addresses the subset of patients who don't respond to checkpoint inhibitor monotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jason Luke 的研究动态
Follow Jason Luke's research updates
留下邮箱，当我们发布与 Jason Luke（University of Pittsburgh Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment